BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 16704730)

  • 21. The human programmed cell death-2 (PDCD2) gene is a target of BCL6 repression: implications for a role of BCL6 in the down-regulation of apoptosis.
    Baron BW; Anastasi J; Thirman MJ; Furukawa Y; Fears S; Kim DC; Simone F; Birkenbach M; Montag A; Sadhu A; Zeleznik-Le N; McKeithan TW
    Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2860-5. PubMed ID: 11854457
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PRMT5 interacts with the BCL6 oncoprotein and is required for germinal center formation and lymphoma cell survival.
    Lu X; Fernando TM; Lossos C; Yusufova N; Liu F; Fontán L; Durant M; Geng H; Melnick J; Luo Y; Vega F; Moy V; Inghirami G; Nimer S; Melnick AM; Lossos IS
    Blood; 2018 Nov; 132(19):2026-2039. PubMed ID: 30082494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LITAF, a BCL6 target gene, regulates autophagy in mature B-cell lymphomas.
    Bertolo C; Roa S; Sagardoy A; Mena-Varas M; Robles EF; Martinez-Ferrandis JI; Sagaert X; Tousseyn T; Orta A; Lossos IS; Amar S; Natkunam Y; Briones J; Melnick A; Malumbres R; Martinez-Climent JA
    Br J Haematol; 2013 Sep; 162(5):621-30. PubMed ID: 23795761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms of action of BCL6 during germinal center B cell development.
    Huang C; Melnick A
    Sci China Life Sci; 2015 Dec; 58(12):1226-32. PubMed ID: 26566802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. POZ-, AT-hook-, and zinc finger-containing protein (PATZ) interacts with human oncogene B cell lymphoma 6 (BCL6) and is required for its negative autoregulation.
    Pero R; Palmieri D; Angrisano T; Valentino T; Federico A; Franco R; Lembo F; Klein-Szanto AJ; Del Vecchio L; Montanaro D; Keller S; Arra C; Papadopoulou V; Wagner SD; Croce CM; Fusco A; Chiariotti L; Fedele M
    J Biol Chem; 2012 May; 287(22):18308-17. PubMed ID: 22493480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The BCL6 proto-oncogene: a leading role during germinal center development and lymphomagenesis.
    Jardin F; Ruminy P; Bastard C; Tilly H
    Pathol Biol (Paris); 2007 Feb; 55(1):73-83. PubMed ID: 16815642
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of Ig/BCL6 translocations with germinal center B lymphocytes in human lymphoid tissues: implications for malignant transformation.
    Yang X; Lee K; Said J; Gong X; Zhang K
    Blood; 2006 Sep; 108(6):2006-12. PubMed ID: 16728698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IRF4 negatively regulates proliferation of germinal center B cell-derived Burkitt's lymphoma cell lines and induces differentiation toward plasma cells.
    Teng Y; Takahashi Y; Yamada M; Kurosu T; Koyama T; Miura O; Miki T
    Eur J Cell Biol; 2007 Oct; 86(10):581-9. PubMed ID: 17651861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of BCL6-interacting proteins by tandem mass spectrometry.
    Miles RR; Crockett DK; Lim MS; Elenitoba-Johnson KS
    Mol Cell Proteomics; 2005 Dec; 4(12):1898-909. PubMed ID: 16147992
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Smc3 dosage regulates B cell transit through germinal centers and restricts their malignant transformation.
    Rivas MA; Meydan C; Chin CR; Challman MF; Kim D; Bhinder B; Kloetgen A; Viny AD; Teater MR; McNally DR; Doane AS; Béguelin W; Fernández MTC; Shen H; Wang X; Levine RL; Chen Z; Tsirigos A; Elemento O; Mason CE; Melnick AM
    Nat Immunol; 2021 Feb; 22(2):240-253. PubMed ID: 33432228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MYC/BCL6 double-hit lymphoma (DHL): a tumour associated with an aggressive clinical course and poor prognosis.
    Li S; Desai P; Lin P; Yin CC; Tang G; Wang XJ; Konoplev SN; Khoury JD; Bueso-Ramos CE; Medeiros LJ
    Histopathology; 2016 Jun; 68(7):1090-8. PubMed ID: 26426741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BCL6 represses CHEK1 and suppresses DNA damage pathways in normal and malignant B-cells.
    Ranuncolo SM; Polo JM; Melnick A
    Blood Cells Mol Dis; 2008; 41(1):95-9. PubMed ID: 18346918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Repression of the PDCD2 gene by BCL6 and the implications for the pathogenesis of human B and T cell lymphomas.
    Baron BW; Zeleznik-Le N; Baron MJ; Theisler C; Huo D; Krasowski MD; Thirman MJ; Baron RM; Baron JM
    Proc Natl Acad Sci U S A; 2007 May; 104(18):7449-54. PubMed ID: 17468402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The gene for interleukin-21 receptor is the partner of BCL6 in t(3;16)(q27;p11), which is recurrently observed in diffuse large B-cell lymphoma.
    Ueda C; Akasaka T; Kurata M; Maesako Y; Nishikori M; Ichinohasama R; Imada K; Uchiyama T; Ohno H
    Oncogene; 2002 Jan; 21(3):368-76. PubMed ID: 11821949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deregulated BCL6 expression recapitulates the pathogenesis of human diffuse large B cell lymphomas in mice.
    Cattoretti G; Pasqualucci L; Ballon G; Tam W; Nandula SV; Shen Q; Mo T; Murty VV; Dalla-Favera R
    Cancer Cell; 2005 May; 7(5):445-55. PubMed ID: 15894265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of t(3;6)(q27;p21) breakpoints in B-cell non-Hodgkin's lymphoma and construction of the histone H4/BCL6 fusion gene, leading to altered expression of Bcl-6.
    Kurata M; Maesako Y; Ueda C; Nishikori M; Akasaka T; Uchiyama T; Ohno H
    Cancer Res; 2002 Nov; 62(21):6224-30. PubMed ID: 12414651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutations of the BCL6 proto-oncogene disrupt its negative autoregulation in diffuse large B-cell lymphoma.
    Pasqualucci L; Migliazza A; Basso K; Houldsworth J; Chaganti RS; Dalla-Favera R
    Blood; 2003 Apr; 101(8):2914-23. PubMed ID: 12515714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acetylation inactivates the transcriptional repressor BCL6.
    Bereshchenko OR; Gu W; Dalla-Favera R
    Nat Genet; 2002 Dec; 32(4):606-13. PubMed ID: 12402037
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FBXO11 inactivation leads to abnormal germinal-center formation and lymphoproliferative disease.
    Schneider C; Kon N; Amadori L; Shen Q; Schwartz FH; Tischler B; Bossennec M; Dominguez-Sola D; Bhagat G; Gu W; Basso K; Dalla-Favera R
    Blood; 2016 Aug; 128(5):660-6. PubMed ID: 27166359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T-cell/histiocyte-rich large B-cell lymphoma: a heterogeneous entity with derivation from germinal center B cells.
    Lim MS; Beaty M; Sorbara L; Cheng RZ; Pittaluga S; Raffeld M; Jaffe ES
    Am J Surg Pathol; 2002 Nov; 26(11):1458-66. PubMed ID: 12409722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.